| Wanda L Lopez, LCDA | |
|
Edificio Montijo # 5, Barceloneta, PR 00617 | |
| (787) 846-4542 | |
| Not Available |
| Full Name | Wanda L Lopez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Edificio Montijo # 5, Barceloneta, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326193970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4982 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wanda L Lopez, LCDA 4 Urb Altamira, Lares, PR 00669-2901 Ph: (787) 487-8373 | Wanda L Lopez, LCDA Edificio Montijo # 5, Barceloneta, PR 00617 Ph: (787) 846-4542 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.
Organizers of the XVIII International AIDS Conference announced today that President Bill Clinton, founder of the William J. Clinton Foundation and 42nd President of the United States, and South African Health Minister Aaron Motsoaledi will be among 19 high-level speakers who will address an estimated 25,000 conference attendees in Vienna this summer.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
A team of scientists led by researchers at the University of Massachusetts Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar (manic depressive) disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders.
As a tumor grows, its cancerous cells ramp up an energy-harvesting process to support its hasty development. This process, called autophagy, is normally used by a cell to recycle damaged organelles and proteins, but is also co-opted by cancer cells to meet their increased energy and metabolic demands.
› Verified 9 days ago
Mrs. Carmen I Rodriguez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Paseo Del Parque, Barceloneta, PR 00617 Phone: 787-746-6829 Fax: 787-846-7351 | |
Suzzanne L Perez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24 Calle Georgetti, Barceloneta, PR 00617 Phone: 787-846-9206 | |
Ms. Marilyn Otero, BSPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Calle Tomas Davila, Barceloneta, PR 00617 Phone: 787-817-9757 | |
Ashley Ann Laureano Otero, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 Carr. 140, Bo. Manati Abajo, Barceloneta, PR 00617 Phone: 787-846-6829 | |
Mrs. Mildred Carrillo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 Calle Georgetti, Barceloneta, PR 00617 Phone: 787-846-2410 | |
Dr. Carem Michelle Cintron, BSPH., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 2 Km 56.6, Barrio Florida Afuera, Barceloneta, PR 00617 Phone: 787-970-8107 Fax: 787-970-8112 | |
Nora Garcia, LCDA. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24 Calle Georgetti, Suite 1, Barceloneta, PR 00617 Phone: 787-846-2630 Fax: 787-846-9206 |